HMD's Principal Activity is the development and manufacture of foetal heart beat monitors and other pregnancy monitoring solutions designed for both home and professional use.
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
1 Week | |
1 Month | |
2022 YTD | |
1 Year | |
vs Sector (1yr) | -21.52% |
vs ASX 200 (1yr) | -24.77% |
Date | Heading | Pages | File Size | Time |
---|---|---|---|---|
HeraMED Limited (HMD) is a technology startup developing a lineup of innovative connected pregnancy monitoring solutions for home use. Harnessing state-of-the-art technology with superior UX/UI, HeraMED creating solutions that are medically accurate, scientifically optimized, safe and affordable.
No incorporation details available.
Head Office | Sydney NSW 2000 |
Website | www.hera-med.com |
Registry | Automic Group |
Auditor | BDO Audit (WA) Pty Ltd |
Date Listed | 12 Dec 2018 |
Date | Event |
---|---|
26/08/2022 | Report (Interim) |
28/10/2022 | Report (Quarterly) |
24/02/2023 | Report (Prelim) |
28/03/2023 | Report (Annual) |
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
HMD directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
The current holdings of HMD directors.
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Citicorp Nominees Pty Ltd | 11/03/2022 | 29,689,010 | 15.70 |
Altor Capital Management Pty Ltd | 11/03/2022 | 10,400,559 | 5.50 |
Holley Pharmaceutical Group Co Ltd | 11/03/2022 | 10,857,385 | 5.74 |
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Year | Closing Price | Last Trade |
---|---|---|
2021 | $0.265 | 30 June |
2020 | $0.087 | 30 June |
2019 | $0.19 | 28 June |
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.